相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A highly selective iron oxide-based imaging nanoparticle for long-term monitoring of drug-induced tumor cell apoptosis
Guanyou Lin et al.
BIOMATERIALS SCIENCE (2021)
Triple-negative breast cancer-Role of immunology: A systemic review
Gizem Oner et al.
BREAST JOURNAL (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with solvent-based taxanes for metastatic breast cancer: A meta-analysis
Hwaryeon Lee et al.
SCIENTIFIC REPORTS (2020)
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
Jingjing Liang et al.
SCIENCE ADVANCES (2020)
Bioinspired Core-Shell Nanoparticles for Hydrophobic Drug Delivery
Guangze Yang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Hydrophobic drug self-delivery systems as a versatile nanoplatform for cancer therapy: A review
Peng Xue et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy
Tianqi Wang et al.
NANOSCALE (2019)
Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy
Yuanyuan Liu et al.
ACTA BIOMATERIALIA (2018)
Engineering nanoparticle strategies for effective cancer immunotherapy
Hong Yeol Yoon et al.
BIOMATERIALS (2018)
Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
Chia-Wei Li et al.
CANCER CELL (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications
Eneko Larraneta et al.
JOURNAL OF FUNCTIONAL BIOMATERIALS (2018)
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
Matthias A. Oberli et al.
NANO LETTERS (2017)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
Combine and conquer: challenges for targeted therapy combinations in early phase trials
Juanita S. Lopez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Triple-negative breast cancer: is there a treatment on the horizon?
Hui Yao et al.
ONCOTARGET (2017)
Lipid-Drug Conjugate for Enhancing Drug Delivery
Danielle Irby et al.
MOLECULAR PHARMACEUTICS (2017)
Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
Yuchen Fan et al.
NANO LETTERS (2017)
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy
Hengfeng Yuan et al.
NATURE NANOTECHNOLOGY (2017)
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Daniela Schmid et al.
NATURE COMMUNICATIONS (2017)
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
Guizhi Zhu et al.
NATURE COMMUNICATIONS (2017)
Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists
Tanja Lovgren et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Nutlin-3a and Cytokine Co-loaded Spermine-Modified Acetalated Dextran Nanoparticles for Cancer Chemo-Immunotherapy
Tomas Bauleth-Ramos et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
Engineering and physical sciences in oncology: challenges and opportunities
Michael J. Mitchell et al.
NATURE REVIEWS CANCER (2017)
Tetraiodothyroacetic acid-conjugated polyethylenimine for integrin receptor mediated delivery of the plasmid encoding IL-12 gene
Fatemeh Sheikhsaran et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Engineering Polymer Hydrogel Nanoparticles for Lymph Node-Targeted Delivery
Stefaan De Koker et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
P. H. Lizotte et al.
NATURE NANOTECHNOLOGY (2016)
A high-density lipoprotein-mediated drug delivery system
Zhong-Cheng Mo et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Enhanced Delivery of Plasmid Encoding Interleukin-12 Gene by Diethylene Triamine Penta-Acetic Acid (DTPA)-Conjugated PEI Nanoparticles
Ali Dehshahri et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2016)
The Nuclear Pore Complex as a Flexible and DynamicGate
Kevin E. Knockenhauer et al.
CELL (2016)
Engineering nanolayered particles for modular drug delivery
Santiago Correa et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation
Shi-Yong Li et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination
Yi-Nan Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade Enhanced Cancer Photodynamic Immunotherapy
Dangge Wang et al.
NANO LETTERS (2016)
Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy
Shengpeng Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Gemcitabine and chlorotoxin conjugated iron oxide nanoparticles for glioblastoma therapy
Qingxin Mu et al.
JOURNAL OF MATERIALS CHEMISTRY B (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer
Yumin Zhang et al.
SCIENTIFIC REPORTS (2016)
Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response
Peipei Zhang et al.
ACS NANO (2015)
CXCR4-Targeted Nanocarriers for Triple Negative Breast Cancers
Asish C. Misra et al.
BIOMACROMOLECULES (2015)
Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice
Lin Yang et al.
NANOSCALE (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
Murugan Kalimutho et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects
Javier Hernandez-Gil et al.
ADVANCED HEALTHCARE MATERIALS (2015)
T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1
Malika Trad et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Nanoparticle-Based Immunotherapy for Cancer
Kun Shao et al.
ACS NANO (2015)
New insights into IL-12-mediated tumor suppression
S. Tugues et al.
CELL DEATH AND DIFFERENTIATION (2015)
Targeting delivery and deep penetration using multistage nanoparticles for triple-negative breast cancer
Shaobo Ruan et al.
RSC ADVANCES (2015)
Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs
Thiruganesh Ramasamy et al.
ACTA BIOMATERIALIA (2014)
Hyaluronic acid-chitosan nanoparticles for co-delivery of M1R-34a and doxorubicin in therapy against triple negative breast cancer
Xiongwei Deng et al.
BIOMATERIALS (2014)
SGN-LIV1A: A Novel Antibody-Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer
Django Sussman et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy
Filipa S. Carvalho et al.
MEDICINAL RESEARCH REVIEWS (2014)
Treatment of 4T1 Metastatic Breast Cancer with Combined Hypofractionated Irradiation and Autologous T-Cell Infusion
Alexander Filatenkov et al.
RADIATION RESEARCH (2014)
Theranostics: An Iron Oxide Nanocarrier for dsRNA to Target Lymph Nodes and Strongly Activate Cells of the Immune System (Small 24/2014)
Macarena Cobaleda-Siles et al.
Small (2014)
In Vivo Tumor Targeting and Image-Guided Drug Delivery with Antibody-Conjugated, Radio labeled Mesoporous Silica Nanoparticles
Feng Chen et al.
ACS NANO (2013)
Tumor vasculature targeting and imaging in living mice with reduced graphene oxide
Sixiang Shi et al.
BIOMATERIALS (2013)
Paclitaxel-Hyaluronic NanoConjugates Prolong Overall Survival in a Preclinical Brain Metastases of Breast Cancer Model
Rajendar K. Mittapalli et al.
MOLECULAR CANCER THERAPEUTICS (2013)
The Preventive Oral Supplementation of a Selenium Nanoparticle-enriched Probiotic Increases the Immune Response and Lifespan of 4T1 Breast Cancer Bearing Mice
M. H. Yazdi et al.
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH (2012)
Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer Model
Lili Bao et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Positron emission tomography imaging of CD105 expression during tumor angiogenesis
Hao Hong et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Anticancer function of polyinosinic-polycytidylic acid
Yu-Sheng Cheng et al.
CANCER BIOLOGY & THERAPY (2010)
Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions
Christian L. Villiers et al.
JOURNAL OF NANOPARTICLE RESEARCH (2010)
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Matthias T. Stephan et al.
NATURE MEDICINE (2010)
The safety and side effects of monoclonal antibodies
Trevor T. Hansel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models
Abhik Bandyopadhyay et al.
PLOS ONE (2010)
Classification of Chemotherapeutic Agents Based on Their Differential In vitro Effects on Dendritic Cells
Hiroaki Tanaka et al.
CANCER RESEARCH (2009)
Breast Cancer Metastasis: Challenges and Opportunities
J. Lu et al.
CANCER RESEARCH (2009)
Anti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature
Shima Uneda et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Functionalized Nanoparticles with Long-Term Stability in Biological Media
Chen Fang et al.
SMALL (2009)
How Location Governs Toll-Like Receptor Signaling
Akanksha Chaturvedi et al.
TRAFFIC (2009)
The TLR3 agonist poly(I:C) targets CD8+T cells and augments their antigen-specific responses upon their adoptive transfer into naive recipient mice
Mohamed L. Salem et al.
VACCINE (2009)
Imagable 4T1 model for the study of late stage breast cancer
Kai Tao et al.
BMC CANCER (2008)
Metastatic breast cancer: The treatment challenge
Stephen E. Jones
CLINICAL BREAST CANCER (2008)
TLR3 can directly trigger apoptosis in human cancer cells
Bruno Salaun et al.
JOURNAL OF IMMUNOLOGY (2006)
Direct costimulatory effect of TLR3 ligand poly(I:C) on human γδ T lymphocytes
D Wesch et al.
JOURNAL OF IMMUNOLOGY (2006)
Eradication of established tumors in mice by a combination antibody-based therapy
Tomoyasu Uno et al.
NATURE MEDICINE (2006)
Albumin-bound paclitaxel: a next-generation taxane
William J. Gradishar
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells
J Riemer et al.
ANALYTICAL BIOCHEMISTRY (2004)
Ultra-large-scale syntheses of monodisperse nanocrystals
J Park et al.
NATURE MATERIALS (2004)
APC-Independent activation of NK cells by the toll-like receptor 3 agonist double-stranded RNA
KN Schmidt et al.
JOURNAL OF IMMUNOLOGY (2004)
CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas - Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients
JP Dales et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Toll-like receptors and innate immunity
R Medzhitov
NATURE REVIEWS IMMUNOLOGY (2001)
Hepatic enzyme induction with phenobarbital and doxorubicin metabolism and myelotoxicity in the rabbit
MG Sturgill et al.
CANCER INVESTIGATION (2000)
分享论文
